- Home
- IRON vs HBNC Comparison
IRON vs HBNC Comparison
Compare IRON & HBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- HBNC
- Stock Information
- Founded
- IRON 2017
- HBNC 1873
- Country
- IRON United States
- HBNC United States
- Employees
- IRON N/A
- HBNC N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- HBNC Major Banks
- Sector
- IRON Health Care
- HBNC Finance
- Exchange
- IRON Nasdaq
- HBNC Nasdaq
- Market Cap
- IRON 1.9B
- HBNC 809.8M
- IPO Year
- IRON N/A
- HBNC N/A
- Fundamental
- Price
- IRON $57.83
- HBNC $15.56
- Analyst Decision
- IRON Strong Buy
- HBNC Hold
- Analyst Count
- IRON 10
- HBNC 2
- Target Price
- IRON $73.70
- HBNC $18.50
- AVG Volume (30 Days)
- IRON 245.9K
- HBNC 158.6K
- Earning Date
- IRON 11-12-2024
- HBNC 01-22-2025
- Dividend Yield
- IRON N/A
- HBNC 4.16%
- EPS Growth
- IRON N/A
- HBNC N/A
- EPS
- IRON N/A
- HBNC 0.48
- Revenue
- IRON N/A
- HBNC $183,718,000.00
- Revenue This Year
- IRON N/A
- HBNC N/A
- Revenue Next Year
- IRON N/A
- HBNC $13.69
- P/E Ratio
- IRON N/A
- HBNC $32.10
- Revenue Growth
- IRON N/A
- HBNC N/A
- 52 Week Low
- IRON $25.60
- HBNC $11.18
- 52 Week High
- IRON $77.60
- HBNC $19.18
- Technical
- Relative Strength Index (RSI)
- IRON 37.45
- HBNC 36.50
- Support Level
- IRON $57.09
- HBNC $14.79
- Resistance Level
- IRON $62.20
- HBNC $16.15
- Average True Range (ATR)
- IRON 2.88
- HBNC 0.39
- MACD
- IRON -0.82
- HBNC -0.07
- Stochastic Oscillator
- IRON 8.16
- HBNC 46.95
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
About HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.